| pubmed-article:3117861 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3117861 | lifeskim:mentions | umls-concept:C0002965 | lld:lifeskim |
| pubmed-article:3117861 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:3117861 | lifeskim:mentions | umls-concept:C0040044 | lld:lifeskim |
| pubmed-article:3117861 | lifeskim:mentions | umls-concept:C2699007 | lld:lifeskim |
| pubmed-article:3117861 | pubmed:issue | 5 Suppl B | lld:pubmed |
| pubmed-article:3117861 | pubmed:dateCreated | 1987-12-4 | lld:pubmed |
| pubmed-article:3117861 | pubmed:abstractText | The coronary lesion in unstable angina consists of disrupted atherosclerotic plaque with nonocclusive intraluminal thrombus, which frequently persists despite heparin anticoagulation. A 12 hour infusion of recombinant tissue-type plasminogen activator combined with heparin effectively lyses the thrombus and stabilizes the clinical syndrome but is associated with a high incidence of bleeding. Therapeutic schemes of thrombolytic therapy associated with a lower bleeding frequency may be useful for the treatment of unstable angina. | lld:pubmed |
| pubmed-article:3117861 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3117861 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3117861 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3117861 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3117861 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3117861 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3117861 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3117861 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3117861 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3117861 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:3117861 | pubmed:issn | 0735-1097 | lld:pubmed |
| pubmed-article:3117861 | pubmed:author | pubmed-author:CollenDD | lld:pubmed |
| pubmed-article:3117861 | pubmed:author | pubmed-author:YasudaTT | lld:pubmed |
| pubmed-article:3117861 | pubmed:author | pubmed-author:LeinbachR CRC | lld:pubmed |
| pubmed-article:3117861 | pubmed:author | pubmed-author:GoldH KHK | lld:pubmed |
| pubmed-article:3117861 | pubmed:author | pubmed-author:JohnsJ AJA | lld:pubmed |
| pubmed-article:3117861 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3117861 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:3117861 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3117861 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3117861 | pubmed:pagination | 91B-95B | lld:pubmed |
| pubmed-article:3117861 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:meshHeading | pubmed-meshheading:3117861-... | lld:pubmed |
| pubmed-article:3117861 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3117861 | pubmed:articleTitle | Thrombolytic therapy for unstable angina pectoris: rationale and results. | lld:pubmed |
| pubmed-article:3117861 | pubmed:affiliation | Cardiac Division, Massachusetts General Hospital, Boston 02114. | lld:pubmed |
| pubmed-article:3117861 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3117861 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:3117861 | pubmed:publicationType | Comparative Study | lld:pubmed |
| pubmed-article:3117861 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:3117861 | pubmed:publicationType | Review | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3117861 | lld:pubmed |
